Skip Navigation

A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases COMRADE

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03317392

Study #:
STUDY00144998

Start Date:
Mar 23, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03317392

View Complete Trial Details & Eligibility at ClinicalTrials.gov